Sphingolipids: membrane microdomains in brain development, function and neurological diseases
- PMID: 28566300
- PMCID: PMC5451547
- DOI: 10.1098/rsob.170069
Sphingolipids: membrane microdomains in brain development, function and neurological diseases
Abstract
Sphingolipids are highly enriched in the nervous system where they are pivotal constituents of the plasma membranes and are important for proper brain development and functions. Sphingolipids are not merely structural elements, but are also recognized as regulators of cellular events by their ability to form microdomains in the plasma membrane. The significance of such compartmentalization spans broadly from being involved in differentiation of neurons and synaptic transmission to neuronal-glial interactions and myelin stability. Thus, perturbations of the sphingolipid metabolism can lead to rearrangements in the plasma membrane, which has been linked to the development of various neurological diseases. Studying microdomains and their functions has for a long time been synonymous with studying the role of cholesterol. However, it is becoming increasingly clear that microdomains are very heterogeneous, which among others can be ascribed to the vast number of sphingolipids. In this review, we discuss the importance of microdomains with emphasis on sphingolipids in brain development and function as well as how disruption of the sphingolipid metabolism (and hence microdomains) contributes to the pathogenesis of several neurological diseases.
Keywords: brain; ganglioside; membrane microdomain; neurological disease; raft; sphingolipid.
© 2017 The Authors.
Conflict of interest statement
We declare we have no competing interests.
Figures



Similar articles
-
Role of cholesterol and sphingolipids in brain development and neurological diseases.Lipids Health Dis. 2019 Jan 25;18(1):26. doi: 10.1186/s12944-019-0965-z. Lipids Health Dis. 2019. PMID: 30683111 Free PMC article. Review.
-
Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.Mol Neurobiol. 2010 Jun;41(2-3):314-40. doi: 10.1007/s12035-009-8096-6. Epub 2010 Feb 3. Mol Neurobiol. 2010. PMID: 20127207 Review.
-
Ceramide function in the brain: when a slight tilt is enough.Cell Mol Life Sci. 2013 Jan;70(2):181-203. doi: 10.1007/s00018-012-1038-x. Epub 2012 Jun 24. Cell Mol Life Sci. 2013. PMID: 22729185 Free PMC article. Review.
-
Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1797-810. doi: 10.2741/3822. Front Biosci (Landmark Ed). 2011. PMID: 21196265 Review.
-
Sphingolipids in neurodegeneration.Neuromolecular Med. 2010 Dec;12(4):301-5. doi: 10.1007/s12017-010-8135-5. Epub 2010 Aug 25. Neuromolecular Med. 2010. PMID: 20737248 Free PMC article. Review.
Cited by
-
Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases.Int J Mol Sci. 2019 Jul 21;20(14):3564. doi: 10.3390/ijms20143564. Int J Mol Sci. 2019. PMID: 31330872 Free PMC article. Review.
-
Gene Expressions Preferentially Influence Cortical Thickness of Human Connectome Project Atlas Parcellated Regions in First-Episode Antipsychotic-Naïve Psychoses.Schizophr Bull Open. 2023 Jul 19;4(1):sgad019. doi: 10.1093/schizbullopen/sgad019. eCollection 2023 Jan. Schizophr Bull Open. 2023. PMID: 37621304 Free PMC article.
-
The role of sphingolipids in psychoactive drug use and addiction.J Neural Transm (Vienna). 2018 Apr;125(4):651-672. doi: 10.1007/s00702-018-1840-1. Epub 2018 Jan 10. J Neural Transm (Vienna). 2018. PMID: 29322265 Review.
-
New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration.Int J Mol Sci. 2021 Jul 7;22(14):7319. doi: 10.3390/ijms22147319. Int J Mol Sci. 2021. PMID: 34298940 Free PMC article. Review.
-
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19.Sci Rep. 2021 Feb 3;11(1):2941. doi: 10.1038/s41598-021-82426-7. Sci Rep. 2021. PMID: 33536486 Free PMC article.
References
-
- van Echten-Deckert G, Herget T. 2006. Sphingolipid metabolism in neural cells. Biochim. Biophys. Acta 1758, 1978–1994. (doi:10.1016/j.bbamem.2006.06.009) - DOI - PubMed
-
- Piccinini M, et al. 2010. Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders. Mol. Neurobiol. 41, 314–340. (doi:10.1007/s12035-009-8096-6) - DOI - PubMed
-
- Aureli M, Grassi S, Prioni S, Sonnino S, Prinetti A. 2015. Lipid membrane domains in the brain. Biochim. Biophys. Acta 1851, 1006–1016. (doi:10.1016/j.bbalip.2015.02.001) - DOI - PubMed
-
- O'Brien JS, Sampson EL. 1965. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res. 6, 537–544. - PubMed
-
- Svennerholm L, Vanier MT. 1973. The distribution of lipids in the human nervous system. IV. Fatty acid composition of major sphingolipids of human infant brain. Brain Res. 55, 413–423. (doi:10.1016/0006-8993(73)90306-5) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical